These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1680438)

  • 1. Fructosamine levels in CAPD: its value as glycemic index.
    Coronel F; Macia M; Cidoncha A; Sanchez A; Tornero F; Barrientos A; Valor R
    Adv Perit Dial; 1991; 7():253-6. PubMed ID: 1680438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical availability of serum fructosamine measurement in diabetic patients with uremia. Use as a glycemic index in uremic diabetes.
    Shoji T; Tabata T; Nishizawa Y; Kikunami K; Matsushita Y; Inoue T; Kenmotsu M; Miki T; Morii H
    Nephron; 1989; 51(3):338-43. PubMed ID: 2918945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated hemoglobin and fructosamine. Indicators of glycemic control in pregnancies complicated by diabetes mellitus.
    Watson WJ; Herbert WN; Prior TW; Chapman JF
    J Reprod Med; 1991 Oct; 36(10):731-4. PubMed ID: 1956013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of HbA1C, glycated serum proteins and albumin, and fructosamine with the 24-h glucose profile of insulin-dependent pregnant diabetics.
    Suhonen L; Stenman UH; Koivisto V; Teramo K
    Clin Chem; 1989 Jun; 35(6):922-5. PubMed ID: 2731364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum glycated albumin and fructosamine in renal dialysis patients.
    Lamb E; Venton TR; Cattell WR; Dawnay A
    Nephron; 1993; 64(1):82-8. PubMed ID: 8502341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three methods to assess metabolic control in diabetic patients on CAPD treatment.
    Bilo HJ; Struijk DG; Boeschoten EW; Oe PL; Donker AJ
    Neth J Med; 1988 Dec; 33(5-6):217-24. PubMed ID: 3221941
    [No Abstract]   [Full Text] [Related]  

  • 7. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reliability of plasma fructosamine and glycosylated hemoglobin assays for assessing glycemic control in diabetic patients on hemodialysis.
    Nunoi K; Kodama T; Sato Y; Iwase M; Yoshizumi H; Kurimoto H; Nishitani H; Nakamura S; Fujishima M
    Metabolism; 1991 Sep; 40(9):986-9. PubMed ID: 1895965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fructosamine (alkaline-reducing activity) for evaluation of glycemic control in diabetic patients.
    Jermendy G; Szelényi J; Bodonyi A; Földi J
    Exp Clin Endocrinol; 1988 Dec; 92(2):171-6. PubMed ID: 3243335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis.
    Wu MS; Yu CC; Wu CH; Haung JY; Leu ML; Huang CC
    Perit Dial Int; 1999; 19 Suppl 2():S179-83. PubMed ID: 10406515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of plasma fructosamine in the assessment of diabetic control.
    Saeed BO; elWali NM; Atabani GS; Elmahdi EM; Mukhtar E
    Trop Geogr Med; 1991; 43(1-2):51-4. PubMed ID: 1750129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.
    Morgan LJ; Marenah CB; Morgan AG; Burden RP; John WG
    Nephrol Dial Transplant; 1990; 5(10):868-73. PubMed ID: 2128382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructosamines in uraemia and renal replacement therapy.
    Beardsworth SF; Vernon V; Harrison D
    Nephrol Dial Transplant; 1989; 4(8):748-9. PubMed ID: 2510086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test].
    Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D
    Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.
    Lee SY; Chen YC; Tsai IC; Yen CJ; Chueh SN; Chuang HF; Wu HY; Chiang CK; Cheng HT; Hung KY; Huang JW
    PLoS One; 2013; 8(3):e57762. PubMed ID: 23469230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus.
    Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG
    Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructosamine as a screening-test for gestational diabetes mellitus: a reappraisal.
    Nasrat HA; Ajabnoor MA; Ardawi MS
    Int J Gynaecol Obstet; 1991 Jan; 34(1):27-33. PubMed ID: 1671017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.